ADBIOTECH Amends 10 Billion Won Convertible Bond Terms, Lower Conversion Price and Dilution Ratio Rises to 41.5%
ADBIOTECH has submitted an amendment to its earlier disclosure regarding the issuance of 10 billion won in 11th series convertible bonds.
The conversion price was lowered by 12% from 2,264 won to 1,992 won, increasing the number of new shares to 5,020,080, representing a 15.70% dilution of outstanding shares.
Including all outstanding convertible bonds, total potential dilution reaches 41.52%, severely impairing existing shareholder value.
The proceeds are intended for acquisition of securities of other corporations, but specific targets and amounts remain undetermined, raising concerns about transparency and efficiency of fund use.
The counterparty changed from Awesome D Investment Union to K-Polaris Investment Union, but its financial information is not disclosed, indicating high governance risk.
Bondholders can demand early redemption from February 2029 at rates ranging from 107.68% to 115.08%.
[AI Summary]The revision of ADBIOTECH's convertible bond terms increases dilution to 15.7% from this issuance alone and combined with existing CBs reaches 41.52% potential dilution. The unclear use of funds and opaque counterparty create significant investment risk.
KOSDAQ Filing Information
[Correction of Description] Report on Major Matters (Decision on Issuance of Convertible Bonds)